Cargando…
Stroke and Cholesterol: 'Enigma Variations'?
The relationship of raised serum cholesterol to coronary atherosclerosis, the main pathophysiological substrate for most ischaemic myocardial events, is clear. Strokes have a more complex aetiology. Hypertension and smoking are strong risk factors for stroke, and their elimination is effective in st...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of Physicians of London
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420977/ https://www.ncbi.nlm.nih.gov/pubmed/9429189 |
_version_ | 1783234508032573440 |
---|---|
author | Stoy, Nicholas S |
author_facet | Stoy, Nicholas S |
author_sort | Stoy, Nicholas S |
collection | PubMed |
description | The relationship of raised serum cholesterol to coronary atherosclerosis, the main pathophysiological substrate for most ischaemic myocardial events, is clear. Strokes have a more complex aetiology. Hypertension and smoking are strong risk factors for stroke, and their elimination is effective in stroke prevention, but cholesterol has been regarded historically as a poor predictor of stroke incidence. The reasons for this are analysed and the relevance of serum cholesterol to stroke prevention discussed. |
format | Online Article Text |
id | pubmed-5420977 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1997 |
publisher | Royal College of Physicians of London |
record_format | MEDLINE/PubMed |
spelling | pubmed-54209772019-01-22 Stroke and Cholesterol: 'Enigma Variations'? Stoy, Nicholas S J R Coll Physicians Lond Overview The relationship of raised serum cholesterol to coronary atherosclerosis, the main pathophysiological substrate for most ischaemic myocardial events, is clear. Strokes have a more complex aetiology. Hypertension and smoking are strong risk factors for stroke, and their elimination is effective in stroke prevention, but cholesterol has been regarded historically as a poor predictor of stroke incidence. The reasons for this are analysed and the relevance of serum cholesterol to stroke prevention discussed. Royal College of Physicians of London 1997 /pmc/articles/PMC5420977/ /pubmed/9429189 Text en © Journal of the Royal College of Physicians of London 1997 http://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) , which permits non-commercial use and redistribution provided that the original author and source are credited. |
spellingShingle | Overview Stoy, Nicholas S Stroke and Cholesterol: 'Enigma Variations'? |
title | Stroke and Cholesterol: 'Enigma Variations'? |
title_full | Stroke and Cholesterol: 'Enigma Variations'? |
title_fullStr | Stroke and Cholesterol: 'Enigma Variations'? |
title_full_unstemmed | Stroke and Cholesterol: 'Enigma Variations'? |
title_short | Stroke and Cholesterol: 'Enigma Variations'? |
title_sort | stroke and cholesterol: 'enigma variations'? |
topic | Overview |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420977/ https://www.ncbi.nlm.nih.gov/pubmed/9429189 |
work_keys_str_mv | AT stoynicholass strokeandcholesterolenigmavariations |